View gene CFTR

General information
Gene symbol CFTR
Gene name cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
Chromosome 7
Chromosomal band q31-q32
Imprinted Unknown
Genomic reference NG_016465.3
Transcript reference NM_000492.3
Associated with diseases END-CF
Citation reference(s) -
Curators (2) Sara Monzón and Javier Alonso
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants
Hidden variants 0
Date created October 09, 2014

Links to other resources
HGNC 1884
Entrez Gene 1080
OMIM - Gene 602421
OMIM - Diseases END-CF (CYSTIC FIBROSIS)


Active transcripts


ID     

Chr     

Name     

NCBI ID     

NCBI Protein ID     

DescendingVariants     
00008 7 cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) NM_000492.3 NP_000483.3 0


Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2014-2018. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.